December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

333.99 -1.54 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,109,803
Open 337.42
Bid (Size) 332.00 (3)
Ask (Size) 333.25 (1)
Prev. Close 335.53
Today's Range 325.73 - 338.35
52wk Range 237.00 - 346.85
Shares Outstanding N/A
Dividend Yield 2.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amgen's Options: A Look at What the Big Money is Thinking
Via Benzinga
3 Biotech Stocks That Could Have Investors Grinning Soon
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential. 
Via InvestorPlace

Performance

YTD
+12.31%
+12.31%
1 Month
+7.43%
+7.43%
3 Month
+11.52%
+11.52%
6 Month
+3.73%
+3.73%
1 Year
+37.29%
+37.29%

More News

Read More
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
Via The Motley Fool
The Top 3 Biotech Stocks to Buy Now Summer 2024
Via InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Via Benzinga
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
Market Whales and Their Recent Bets on AMGN Options
Via Benzinga
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
Via InvestorPlace
Topics ETFs
3 Fabulous Growth Stocks to Buy and Hold Forever
Via InvestorPlace
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
3 Stocks That Are Melting Up. Is There Room to Run?
Via InvestorPlace
A Closer Look at Amgen's Options Market Dynamics
Via Benzinga
10 Best Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
Via Investor's Business Daily
Q2 Earnings Season Scorecard, Economic Outlook And Analyst Reports For Nvidia, Meta & Others
Via Talk Markets
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Via Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
Via Investor's Business Daily
7 Dividend Stocks That Just Raised Their Payouts: July 2024
Via InvestorPlace
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
Via Investor's Business Daily
3 Quantum AI Stocks That Could Redefine Computing
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Biotech Stocks to Buy Now: Q3 Edition
Via InvestorPlace
CPI Data Sparks Rally in Biotech Stocks
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.